According to the data from Bloomberg.com, the thirteen analysts who follow Exelon Co (NASDAQ: EXC) have given the company an average rating of “Moderate Buy.” When it comes to maintaining stocks in one’s portfolio, only two analysts recommend doing so, whereas nine research experts recommend purchasing the stock.

Most analysts who updated their coverage of the stock in the previous year have set a price target of $46.64 for the coming year.

This price target is expected to be reached within the next 12 months.

Recently, the company has been in communication with a variety of analysts, and they have provided their feedback. Wells Fargo & Company disclosed their decision to reduce their price target for Exelon from $47.00 to $45.00 in a research note made public on February 15th.

In a research note published on February 15th, BMO Capital Markets lowered their “outperform” rating on Exelon shares and decreased their target price on the company’s stock from $46.00 to $45.00.

These changes were made in response to the company’s recent stock performance.

In a research note published on Friday, November 4th, Mizuho Investment Research reduced its “buy” rating and target price on Exelon shares from $47.00 to $39.00.

The price target was also reduced from $47.00. Credit Suisse Group has assigned an “outperform” rating to Exelon and has increased its price objective from $42.00 to $46.00.

This information was included in a report released on Monday, January 23rd.

Morgan Stanley previously gave Exelon an “underweight” rating, which was changed to an “overweight” rating in a research note published on Thursday, December 15th.

Before this point, the firm had given the company an “underweight” rating.
NASDAQ: EXC was first available for trading on Thursday with an opening price of $39.75.

The company’s simple moving average over the past fifty days is $42.25, and the company’s simple moving average over the past two hundred days is $40.54.

During the previous calendar year, the price of a share of Exelon stock ranged from a high of $50.71 to a low of $35.19.

The debt-to-equity ratio stands at 1.44, the quick ratio stands at 0.62, and the current ratio stands at 0.69.

The company’s market value is $39.52 billion, its price-to-earnings ratio is 18.15, its price-to-earnings-to-growth ratio is 2.66, and its beta value is 0.60.

The company’s price-to-earnings-to-growth ratio is 2.66.

The most recent quarterly results report for Exelon (NASDAQ: EXC) was presented on February 14th, which was a Tuesday.

The company’s quarterly profits came in at $0.43 per share, in line with the consensus estimate of $0.43 per share among market professionals.

Exelon achieved a 9.30% return on equity and a net margin of 11.37& amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; actual amp revenue for the quarter was $4.67 billion, which was a significant increase over the average expectation of $4.14 billion for the quarter’s revenue.

The company reported earnings per share of $0.90 in the previous year’s financial statements for the same period. Compared to the numbers for the same period in the year before, Exelon reported a 5.5% increase in revenue for the quarter that just ended.

Professionals in the relevant field hold the majority opinion that Exelon will report earnings of $2.35 per share in 2017.

In addition, the company disclosed that it would be implementing a quarterly dividend, which is scheduled to be paid out on March 10th. Shareholders on record as of February 27th will be eligible to receive a $0.36 dividend payment when it is paid out.

The day that the dividend is no longer payable is this coming Friday, February 24th.

Exelon has increased its dividend every quarter, which currently stands at $0.34 per share.

The investor will receive a dividend payment of $1.44 per year and a yield of 3.62% from this investment.

Exelon has a payout ratio of 65.75 percent at the moment.

During the previous few months, hedge funds have either increased or decreased the amount of the company’s stock that they hold. Cowa LLC purchased a new investment in Exelon during the third quarter at approximately $26,000.

The Exelon stock was the target of a fresh investment of $29,000 that Concord Wealth Partners made over the final three months of 2018.

The Independence Bank of Kentucky made a 133.3% increase in its stock holdings of Exelon during the last three months of 2018.

As a result of purchasing an additional 400 shares during the time above period, Independence Bank of Kentucky now owns a total of 700 shares of the company’s stock, which is $30,000.

These shares were purchased during the same period as the initial purchase. First Financial Corporation’s holdings of Exelon increased by a factor of 47.0% during the fourth quarter of the fiscal year.

The stock holdings of First Financial Corp. (IN) have been increased over time by purchasing an additional 235 shares, bringing the total number of shares it owns to 735, currently valued at $32,000.

This was accomplished through the purchase of additional shares.

During the fourth quarter, Affiance Financial LLC spent an additional $32,000 to expand its holdings in Exelon by purchasing additional company stock shares.

Institutional investors and hedge funds own a combined total of 80.60 percent of the company’s stock.

The Exelon Corporation is a holding company responsible for several different utilities engaged in the production, transmission, and distribution of electric power.

The companies that make up its segments are as follows:
The Commonwealth Edison Company (ComEd)
The PECO Energy Company (PECO)
The Baltimore Gas and Electric Company (BGE)
The Potomac Electric Power Company (Pepco)
The Delmarva Power & Light Company (DPL)
The Atlantic City Electric Company (ACE).

The post Brokerages have given Exelon Co. (NASDAQ:EXC) an average recommendation of “Moderate Buy.” appeared first on Best Stocks.